Byetta, Januvia, Victoza Lawsuits
Diabetes Drugs Byetta, Januvia and Victoza Linked to Pancreatic Cancer
The popular diabetes drugs Byetta, Januvia and Victoza have been linked to the development of pancreatic cancer. Pancreatic cancer is serious and can be deadly. Byetta, Januvia and Victoza are part of a class of drugs known as incretin mimetics, which have previously been linked to a potential risk of pancreatitis, or inflammation of the pancreas. Increasing evidence suggests that these medications cause chronic, asymptomatic pancreatitis, which may ultimately lead to pancreatic cancer.
A study published in the medical journal “Diabetes” on March 17, 2013, confirms that users of the medications are more likely to have increased pancreatic mass and precancerous cells, which are cells that may eventually evolve into tumors or pancreatic cancer.
On March 14, 2013, the FDA issued a Drug Safety Communication in response to the journal’s findings. The FDA indicated that they are evaluating the data and plan to conduct additional testing on the samples collected by researchers to further review the potential pancreatic toxicity associated with these drugs.
Doctors prescribe drugs like Januvia, Janumet, Byetta and Victoza because the drugmakers claim that these products can help their patients control their diabetes. Instead, many patients are developing conditions far worse than diabetes as a result of taking the drugs. Treating severe side-effects from these drugs requires long-term medical care and, in many cases, hospitalization.
If you or a loved one has taken either Byetta, Januvia or Victoza and are injured as a result, contact the CQH Firm for a free legal consultation at 1- (844) 677-4276 or (215) 496-1012 or at email@example.com.